摘要
多个国家临床指南和专家共识均指出,经导管肾动脉消融去肾神经术(RDN)治疗高血压是除了改善生活方式和药物治疗以外第三种抗高血压治疗方法。射频、超声、乙醇等多种不同方式的RDN器械被研发并开展了系列临床研究。现将详细分析这些不同RDN消融技术的基本特性、临床研究结果及存在的问题和争议,并对未来的发展方向进行探讨。
With recent robust evidence from clinical trials and real-world data showing the safety and efficacy of both ultrasound and radiofrequency-based approaches,several clinical consensus statements or hypertension guidelines for the management of arterial hypertension on the catheter-based renal denervation(RDN)had been published,confirming RDN represents another treatment option for adult patients with uncontrolled hypertension.We reviewed the results from clinical trials based on these current RDN technologies,which including radiofrequency ablation,ultrasound ablation,alcohol injection and cryoablation,and discussed the controversy and future perspective of RDN for the treatment of hypertension.
作者
亢园园
罗淞元
许建忠
罗建方
卢成志
KANG Yuanyuan;LUO Songyuan;XU Jianzhong;LUO Jianfang;LU Chengzhi(Department of Hypertension,Ruijin Hospital Shanghai Jiao Tong University School of Medicine,Shanghai Institute of Hypertension,Shanghai 200025,China;Department of Cardiology,Guangdong Provincial People’s Hospital,Guangzhou 510030,Guangdong,China;Department of Cardiology,Tianjin First Central Hospital,Tianjin 300110,China)
出处
《心血管病学进展》
CAS
2024年第10期875-879,884,共6页
Advances in Cardiovascular Diseases
基金
上海市自然科学基金(21ZR1454100)
上海市公共卫生三年行动计划青年人才项目(GWV1-11.2-YQ09)。
关键词
去肾神经术
射频
超声
高血压
Renal denervation
Radio frequency
Ultrasound
Hypertension
